Carillo, Gabriel C.
HRN: 21-87-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
CLOXACILLIN 500MG (CAP)
09/12/2022
09/21/2022
ORAL
500mg
Qid
CAP MR Covid 19 Pneumonia Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Dose
Overall appropriateness: No Wrong Choice